{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:47:37Z","timestamp":1770108457623,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFD1400400"],"award-info":[{"award-number":["2023YFD1400400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32360689"],"award-info":[{"award-number":["32360689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32260694"],"award-info":[{"award-number":["32260694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22364008"],"award-info":[{"award-number":["22364008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioorg.2026.109508","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:04:44Z","timestamp":1768435484000},"page":"109508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery and mechanistic insights of novel Piperlongumine analogs as potent Bcr-Abl kinase inhibitors"],"prefix":"10.1016","volume":"170","author":[{"given":"Guanglong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesha","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuguo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuqiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109508_bb0005","doi-asserted-by":"crossref","unstructured":"D.A. Arber, A. Orazi, R. Hasserjian, J. Thiele, M.J. Borowitz, M.M. Le Beau, C.D. Bloomfield, M. Cazzola, J.W. Vardiman, The 2016 Revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood 127 (2016) 2391\u20132405. Doi: https:\/\/doi.org\/10.1182\/blood-2016-03-643544.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"10.1016\/j.bioorg.2026.109508_bb0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13287-021-02659-1","article-title":"Chronic myeloid leukemia stem cells: targeting therapeutic implications","volume":"12","author":"Mojtahedi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bioorg.2026.109508_bb0015","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood-2015-10-674242","article-title":"Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2026.109508_bb0020","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1\u2013positive chronic myeloid leukemia","volume":"113","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2026.109508_bb0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOH.0000000000000403","article-title":"Resistance in chronic myeloid leukemia: definitions and novel therapeutic agents","volume":"25","author":"Talati","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bioorg.2026.109508_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood-2016-09-739086","article-title":"Ponatinib efficacy and safety in Philadelphia chromosome\u2013positive leukemia: final 5-year results of the phase 2 PACE trial","volume":"132","author":"Cortes","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2026.109508_bb0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.18632\/oncotarget.333","article-title":"Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy","volume":"2","author":"Chomel","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.109508_bb0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.med.53.082901.103853","article-title":"Recent advancements in the treatment of chronic myelogenous leukemia","volume":"53","author":"O'Dwyer","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bioorg.2026.109508_bb0045","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1038\/s41375-021-01277-3","article-title":"Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigms","volume":"35","author":"Short","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2026.109508_bb0050","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0040-4020(01)82575-8","article-title":"Alkaloids of Piper longum Linn\u2014I\u00a0: structure and synthesis of piperlongumine and piperlonguminine","volume":"23","author":"Chatterjee","year":"1967","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.109508_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejps.2012.12.003","article-title":"Overview of the therapeutic potential of piplartine (piperlongumine)","volume":"48","author":"Bezerra","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.109508_bb0060","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ptr.2432","article-title":"Antiplatelet activities of newly synthesized derivatives of Piperlongumine","volume":"22","author":"Park","year":"2008","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bioorg.2026.109508_bb0065","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.bmcl.2014.10.054","article-title":"Synthesis and biological evaluation of piperlongumine derivatives as potent anti-inflammatory agents","volume":"24","author":"Seo","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109508_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00011-014-0708-6","article-title":"Vascular barrier protective effects of piperlonguminine in vitro and in vivo","volume":"63","author":"Ku","year":"2014","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bioorg.2026.109508_bb0075","first-page":"785","article-title":"Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells","volume":"20","author":"Kong","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2026.109508_bb0080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/aps.2014.141","article-title":"Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38\/JNK pathways","volume":"36","author":"Xiong","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2026.109508_bb0085","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/neuonc\/nou088","article-title":"Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells","volume":"16","author":"Kim","year":"2014","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.bioorg.2026.109508_bb0090","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.3390\/ijms22094478","article-title":"Xanthohumol for human malignancies: chemistry, pharmacokinetics and molecular targets","volume":"22","author":"Harish","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109508_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114738","article-title":"Discovery of a novel piperlongumine analogue as a microtubule polymerization inhibitor with potent anti-angiogenic and anti-metastatic efficacy","volume":"243","author":"Qin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0100","doi-asserted-by":"crossref","first-page":"15115","DOI":"10.1073\/pnas.1212802109","article-title":"Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs","volume":"109","author":"Adams","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.109508_bb0105","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1021\/acs.jmedchem.9b01541","article-title":"Urea derivatives in modern drug discovery and medicinal chemistry","volume":"63","author":"Ghosh","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0110","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/0929867323666161129124915","article-title":"Ureas: applications in drug design","volume":"24","author":"Jagtap","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104028","article-title":"Synthesis and anticancer activity of some pyrimidine derivatives with aryl urea moieties as apoptosis-inducing agents","volume":"101","author":"Kilic-Kurt","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bjc.2013.334","article-title":"Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)\/akt signaling","volume":"109","author":"Wan","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2026.109508_bb0125","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1517\/13543784.2012.733695","article-title":"Tivozanib: current status and future directions in the treatment of solid tumors","volume":"21","author":"Pal","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bioorg.2026.109508_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104401","article-title":"Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor","volume":"105","author":"Fan","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bcp.2015.03.014","article-title":"Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent","volume":"95","author":"Sun","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109508_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2016.05.021","article-title":"Designing piperlongumine-directed anticancer agents by an electrophilicity-based prooxidant strategy: a mechanistic investigation","volume":"97","author":"Yan","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2026.109508_bb0145","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.3390\/molecules26113243","article-title":"Piperlongumine analogs promote A549 cell apoptosis through enhancing ROS generation","volume":"26","author":"Sun","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109508_bb0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejmech.2014.05.070","article-title":"Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents","volume":"82","author":"Wu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104424","article-title":"Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing hydrazone fragment as potent and selective anticancer agents","volume":"105","author":"Xu","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0160","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/14756366.2020.1740696","article-title":"Antiproliferative chromone derivatives induce K562 cell death through endogenous and exogenous pathways","volume":"35","author":"Jiao","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0165","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1021\/acs.jafc.2c01141","article-title":"Fabrication of isopropanolamine-decorated coumarin derivatives as novel quorum sensing inhibitors to suppress plant bacterial disease","volume":"70","author":"Feng","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0170","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.1021\/acs.jafc.3c03738","article-title":"Design, synthesis, and mechanism of novel 9-aliphatic amine tryptanthrin derivatives against phytopathogenic bacteria","volume":"71","author":"Zhang","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112504","article-title":"Targeting topoisomerase II with trypthantrin derivatives: discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12dione as an antiproliferative agent and to treat cancer","volume":"202","author":"Catanzaro","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109508_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140226","article-title":"Targeting tubulin protein to combat fungal disease: design, synthesis, and its new mechanistic insights of benzimidazole hydrazone derivatives","volume":"300","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.109508_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004586","article-title":"AutoDockFR: advances in protein-ligand docking with explicitly specified binding site flexibility","volume":"11","author":"Ravindranath","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bioorg.2026.109508_bb0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109508_bb0200","series-title":"Profiles of Drug Substances","first-page":"273","article-title":"Validation of in-vitro bioassay methods: Application in herbal drug research","author":"Indrayanto","year":"2021"},{"key":"10.1016\/j.bioorg.2026.109508_bb0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2019.02.034","article-title":"Piperlongumine increases sensitivity of colorectal cancer cells to radiation: involvement of ROS production via dual inhibition of glutathione and thioredoxin systems","volume":"450","author":"Wang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.109508_bb0210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2026.109508_bb0215","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","article-title":"ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis","volume":"97","author":"Wang","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bioorg.2026.109508_bb0220","series-title":"Gene Expression Analysis: Methods and Protocols","first-page":"1","article-title":"Overview of gene expression analysis: Transcriptomics","author":"Raghavachari","year":"2018"},{"key":"10.1016\/j.bioorg.2026.109508_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104772","article-title":"Piperlongumine, a potent anticancer phytotherapeutic: perspectives on contemporary status and future possibilities as an anticancer agent","volume":"156","author":"Tripathi","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2026.109508_bb0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.32604\/or.2022.025323","article-title":"PI3K\/AKT signaling pathway as a critical regulator of cisplatin response in tumor cells","volume":"29","author":"Nasrpour Navaei","year":"2021","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bioorg.2026.109508_bb0235","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V86.2.726.bloodjournal862726","article-title":"Phosphatidylinositol-3 kinase activity is regulated by BCR\/ABL and is required for the growth of Philadelphia chromosome-positive cells","volume":"86","author":"Skorski","year":"1995","journal-title":"Blood"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:10:59Z","timestamp":1770066659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"alternative-id":["S0045206826000441"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109508","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and mechanistic insights of novel Piperlongumine analogs as potent Bcr-Abl kinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109508"}}